Tacrine for Alzheimer's disease-Reference-Cited by-同舟云学术

Tacrine for Alzheimer's disease

Published:1999-01-25 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Qizilbash Nawab¹,Birks Jacqueline²,López Arrieta Jess³,Lewington Sarah⁴,Szeto Samuel⁵

Affiliation:

1. SmithKline Beecham; New Frontiers Science Park (South) Third Avenue Harlow Essex UK CM19 5AW

2. University of Oxford; Centre for Statistics in Medicine; Wolfson College Linton Road Oxford UK OX2 6UD

3. Hospital Universitario La Paz-Cantoblanco; Geriatric Department; Ctra de Colmenar km 14,500 Madrid Spain 28049

4. University of Oxford; Clinical Trial Service Unit and Epidemiological Studies Unit; Richard Doll Building, Old Road Campus Roosevelt Drive Oxford UK OX3 7LF

5. Oxford UK

Publisher

Wiley

Subject

Pharmacology (medical)

Reference58 articles.

1. A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease;Davis;New Engl J Med,1992

2. A double-blind, placebo-controlled, enriched population study of tacrine in patients with Alzheimer's disease;Forette;Eur J Neurol,1995

3. An enriched-population, double-blind, placebo-controlled, crossover study of tacrine and lecithin in Alzheimer's disease;Foster;Dementia,1996

4. A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease;Knapp;JAMA,1994

5. A double-blind, placebo controlled, multicentre study of tacrine for Alzheimer's disease;Wood;International Journal of Geriatric Psychiatry,1994

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structure-based inhibition of acetylcholinesterase and butyrylcholinesterase with 2-Aryl-6-carboxamide benzoxazole derivatives: synthesis, enzymatic assay, and in silico studies;Molecular Diversity;2024-03-30

2. Sulfonamido, amido heterocyclic adducts of tetrazole derivatives as BACE1 inhibitors: in silico exploration;Molecular Diversity;2024-01-25

3. Multi-Target-Directed Cinnamic Acid Hybrids Targeting Alzheimer’s Disease;International Journal of Molecular Sciences;2024-01-01

4. Nanotechnology‐empowered therapeutics targeting neurodegenerative diseases;WIREs Nanomedicine and Nanobiotechnology;2023-05-30

5. Aducanumab: A new hope in Alzheimer's disease;Health Sciences Review;2022-09